Approximately 50% of human mammary carcinomas express abnormally high levels of CYCLIN D1 [71–75] that are maintained throughout subsequent stages of breast cancer progression from in situ carcinoma to invasive carcinomas [74, 76, 77]. Here, CCND1 is linked to breast cancer.